News Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease | Emergent BioSolutions Inc. GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an…Super UserMarch 16, 2020
News NEA Closes On $3.6B for New Fund with Focus on Early-Stage Technology and Healthcare Investments MENLO PARK, Calif. and NEW YORK, March 11, 2020 /PRNewswire/ -- New Enterprise Associates, Inc. (NEA) today announced that it…Super UserMarch 16, 2020
News Uniform nanoparticle vaccines Precise loading of diverse peptides for vaccination is enabled by a strategy for peptide–TLR7/8 conjugate self-assembly of uniform nanoparticles. The…Super UserMarch 16, 2020
News FDA and FTC Send Joint Warning Letters to Seven Companies for “Selling Fraudulent COVID-19 Products” | Wilson Sonsini Goodrich & Rosati – JDSupra The number of cases of SARS-CoV-2 coronavirus infection, and COVID-19, the disease caused by the virus, continue to increase in…Super UserMarch 16, 2020
News University of Maryland athletics announces spectator restrictions amid coronavirus outbreak – Baltimore Sun University of Maryland athletics on Wednesday announced a series of safety measures for its home events amid concern over the…Super UserMarch 16, 2020
News New Enterprise Associates Amasses $3.6 Billion for 17th Fund – WSJ New Enterprise Associates has raised $3.6 billion for its 17th venture fund, the largest in the more than 42-year history…Super UserMarch 16, 2020
News Top 15 Best-Selling Drugs of 2019 GEN publishes its updated annual A-List highlighting the top 15 best-selling drugs of 2019. Eleven of last year’s 15 top-selling…Super UserMarch 16, 2020
News All you need to know about TBS Osteo – Medimaps All TBS Osteo features and main arguments. Included, in greater detail. What is TBS Osteo powered by TBS iNsight and…Super UserMarch 16, 2020
News Emergent Biosolutions, Inc. (NYSE:EBS), Novavax, Inc. (NASDAQ:NVAX) – Emergent BioSolutions CEO Talks Coronavirus Vaccine Development | Benzinga Global life sciences company Emergent Biosolutions Inc EBS 6.61% CEO Bob Kramer said Thursday that his company's partnership with Novavax,…Super UserMarch 16, 2020
News FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections | Business Wire GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global…Super UserMarch 16, 2020